Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Thye Dirk
CEO AND CHIEF MEDICAL OFFICER at Quince Therapeutics. Filing since 8 Aug 2023.
CIK 0001638945
Company
Date
Role
Action
Shares
Amount
Of holding
QNCX
Quince Therapeutics, Inc.
30 Aug 2024
CEO AND CHIEF MEDICAL OFFICER
Bought
77,000
$53.90K
10.0%
QNCX
Quince Therapeutics, Inc.
29 Aug 2024
CEO AND CHIEF MEDICAL OFFICER
Bought
77,500
$53.48K
11.2%
QNCX
Quince Therapeutics, Inc.
10 Aug 2023
Chief Executive Officer
Bought
88,000
$110.88K
24.4%
QNCX
Quince Therapeutics, Inc.
8 Aug 2023
Chief Executive Officer
Bought
80,000
$99.20K
28.5%
4 decisions on file.